Autoimmune diabetes

Amino acid-based therapy for autoimmune diabetes (TIDM): L-Serine, a non-essential amino acid, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 21/March/2018, 10.19 pm
Amino acid-based therapy for autoimmune diabetes (TIDM): L-Serine, a non-essential amino acid, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 21/March/2018, 10.19 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

A candy way to treat blood sugar disease: Sugar-based therapy for autoimmune diabetes (TIDM): D-Mannose, a C-2 epimer of glucose, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 17/March/2018, 8.28 am
A candy way to treat blood sugar disease: Sugar-based therapy for autoimmune diabetes (TIDM): D-Mannose, a C-2 epimer of glucose, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 17/March/2018, 8.28 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

A sweet way to say no to Autoimmune diabetes (TIDM): Sugar-based therapy for autoimmune diabetes (TIDM): Trehalose, a natural sweetener isolated from mushrooms among others,  increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 16/March/2018, 7.20 am
A sweet way to say no to Autoimmune diabetes (TIDM): Sugar-based therapy for autoimmune diabetes (TIDM): Trehalose, a natural sweetener isolated from mushrooms among others,  increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 16/March/2018, 7.20 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

Milk products-based therapy for reversing autoimmune diabetes (TIDM): Rumenic acid/Bovinic acid, a conjugated linoleic acid found  abundantly in dairy products, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 8/March/2018, 10.41 pm
Milk products-based therapy for reversing autoimmune diabetes (TIDM): Rumenic acid/Bovinic acid, a conjugated linoleic acid found  abundantly in dairy products, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 8/March/2018, 10.41 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

Small-molecule based therapy for reversing autoimmune diabetes (TIDM): Lactoferrin, a globular glycoprotein commonly found in secretory fluids, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 8/March/2018, 7.06 am
Small-molecule based therapy for reversing autoimmune diabetes (TIDM): Lactoferrin, a globular glycoprotein commonly found in secretory fluids, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 8/March/2018, 7.06 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

Hypothermia-based therapy for autoimmune diabetes (TIDM): Mild Hypothermia increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 6/March/2018, 6.24 pm
Hypothermia-based therapy for autoimmune diabetes (TIDM): Mild Hypothermia increases PD-L1 expression, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 6/March/2018, 6.24 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more
Start Typing